Skip to content
OpenDue April 9, 2026

Defense Logistics Agency (DLA) Request for Information (RFI): Country of Origin and API Source Disclosure for Generic Pharmaceutical Products

DEPT OF DEFENSE

About this opportunity

Defense Logistics Agency (DLA) Request for Information (RFI): Country of Origin and API Source Disclosure for Generic Pharmaceutical Products 1. Purpose In response to proposed legislation, the Defense Logistics Agency (DLA) is issuing this Request for Information (RFI) to gather data from industry regarding the manufacturing origin and active pharmaceutical ingredient (API) sourcing for generic pharmaceutical products. This RFI is for market research and planning only and does not constitute a solicitation or a commitment by the Government. 2. Background DLA is evaluating supply chain transparency and potential country?of?origin disclosure requirements for generic pharmaceuticals. Proposed legislation (summarized below) request that generic medicine include specific additional labeling re...

Finding similar opportunities...